Role of Complement Activation in Obliterative Bronchiolitis Post Lung Transplantation
Hidemi Suzuki,Mark E. Lasbury,Lin Fan,Ragini Vittal,Elizabeth A. Mickler,Heather L. Benson,Rebecca Shilling,Qiang Wu,Daniel J. Weber,Sarah R. Wagner,Melissa Lasaro,Denise Devore,Yi Wang,George E. Sandusky,Kelsey Lipking,Pankita Pandya,John Reynolds,Robert Love,Thomas Wozniak,Hongmei Gu,Krista M. Brown,David S. Wilkes
DOI: https://doi.org/10.4049/jimmunol.1202242
2013-01-01
The Journal of Immunology
Abstract:Obliterative bronchiolitis (OB) post-lung transplantation involves IL-17-regulated autoimmunity to type V collagen and alloimmunity, which could be enhanced by complement activation. However, the specific role of complement activation in lung allograft pathology, IL-17 production, and OB is unknown. The current study examines the role of complement activation in OB. Complement-regulatory protein (CRP) (CD55, CD46, complement receptor 1-related protein y/CD46) expression was downregulated in human and murine OB; and C3a, a marker of complement activation, was upregulated locally. IL-17 differentially suppressed complement receptor 1-related protein y expression in airway epithelial cells in vitro. Neutralizing IL-17 recovered CRP expression in murine lung allografts and decreased local C3a production. Exogenous C3a enhanced IL-17 production from alloantigen- or autoantigen (type V collagen)-reactive lymphocytes. Systemically neutralizing C5 abrogated the development of OB, reduced acute rejection severity, lowered systemic and local levels of C3a and C5a, recovered CRP expression, and diminished systemic IL-17 and IL-6 levels. These data indicated that OB induction is in part complement dependent due to IL-17-mediated downregulation of CRPs on airway epithelium. C3a and IL-17 are part of a feed-forward loop that may enhance CRP downregulation, suggesting that complement blockade could be a therapeutic strategy for OB.